(Q36634279)

15 August 2017

1 reference

title

Emerging drugs for diabetic foot ulcers (English)

1 reference

15 August 2017

Nina Petrova

1

1 reference

15 August 2017

Michael Edmonds

series ordinal

2

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 November 2006

1 reference

Expert Opinion on Emerging Drugs

15 August 2017

published in

1 reference

15 August 2017

volume

11

1 reference

15 August 2017

issue

4

1 reference

15 August 2017

page(s)

709-724

1 reference

The molecular biology of chronic wounds and delayed healing in diabetes

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

Healing diabetic neuropathic foot ulcers: are we getting better?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

Microvascular response to tissue injury and capillary ultrastructure in the foot skin of type I diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

21 January 2018

The diabetic foot, 2003.

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

Role of the microcirculation in diabetic foot ulceration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

Current concepts. Vascular and microvascular disease of the foot in diabetes. Implications for foot care

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

Infection in the neuroischemic foot

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

Prediction of diabetic foot ulcer occurrence using commonly available clinical information: the Seattle Diabetic Foot Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

Science, medicine and the future: healing chronic wounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

Lack of insulin-like growth factor 1 (IGF1) in the basal keratinocyte layer of diabetic skin and diabetic foot ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

Transforming growth factor-beta 1, 2, 3 and receptor type I and II in diabetic foot ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

Role of neuropathy and plasma nitric oxide in recurrent neuropathic and neuroischemic diabetic foot ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

Impaired wound healing in patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

Proteases and the diabetic foot syndrome: mechanisms and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

Fibroblasts derived from human chronic diabetic wounds have a decreased proliferation rate, which is recovered by the addition of heparin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

Inhibited proliferation of fibroblasts derived from chronic diabetic wounds and normal dermal fibroblasts treated with high glucose is associated with increased formation of l-lactate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

Insulin resistance: a multifaceted metabolic syndrome. Insights gained using a low-dose insulin infusion technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

Glucose effects on skin keratinocytes: implications for diabetes skin complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

Effect of glycation on basic fibroblast growth factor induced angiogenesis and activation of associated signal transduction pathways in vascular endothelial cells: possible relevance to wound healing in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

Evaluation of removable and irremovable cast walkers in the healing of diabetic foot wounds: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

A randomized trial of two irremovable off-loading devices in the management of plantar neuropathic diabetic foot ulcers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

Wound healing and its impairment in the diabetic foot

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

Wound dressings in diabetic foot disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

A systematic review of foot ulcer in patients with Type 2 diabetes mellitus. II: treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

Treatment for diabetic foot ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

Sustained silver-releasing dressing in the treatment of diabetic foot ulcers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

Antimicrobial activities of silver dressings: an in vitro comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

Psychological aspects of diabetic neuropathic foot complications: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

Human epidermal growth factor enhances healing of diabetic foot ulcers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

Effectiveness of platelet releasate for the treatment of diabetic neuropathic foot ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

Randomized prospective double-blind trial in healing chronic diabetic foot ulcers. CT-102 activated platelet supernatant, topical versus placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

Cultured allogeneic skin cells are effective in the treatment of chronic diabetic leg and foot ulcers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

A new autologous keratinocyte dressing treatment for non-healing diabetic neuropathic foot ulcers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

Cutaneous tissue engineering and lower extremity wounds (part 2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

Outcomes of allogenic acellular matrix therapy in treatment of diabetic foot wounds: an initial experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

HYAFF 11-based autologous dermal and epidermal grafts in the treatment of noninfected diabetic plantar and dorsal foot ulcers: a prospective, multicenter, controlled, randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

Tissue and cellular approaches to wound repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

Lentiviral gene therapy with platelet-derived growth factor B sustains accelerated healing of diabetic wounds over time

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

Nitric oxide: a newly discovered function on wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

Nitric oxide enhances experimental wound healing in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5'-N-methyluronamide, is protective in two murine models of colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

Effect of dalteparin on healing of chronic foot ulcers in diabetic patients with peripheral arterial occlusive disease: a prospective, randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

Enhanced healing of ulcers in patients with diabetes by topical treatment with glycyl-l-histidyl-l-lysine copper

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

The pivotal role of offloading in the management of neuropathic foot ulceration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

What is the future of diabetic wound care?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.709

10.1517/14728214.11.4.709

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference